<DOC>
<DOCNO>
EP-0017570
</DOCNO>
<TEXT>
<DATE>
19801015
</DATE>
<IPC-CLASSIFICATIONS>
C12N-5/00 C12N-5/06 A61K-38/21 C07K-14/555 <main>C12P-21/00</main> C07K-14/435 C12P-21/00 
</IPC-CLASSIFICATIONS>
<TITLE>
process for the preparation of interferon and culture medium composition used in it.
</TITLE>
<APPLICANT>
merck & co incus<sep>merck & co. inc.<sep>merck &amp; co., inc.126, east lincoln avenue p.o. box 2000rahway new jersey 07065-0900us<sep>merck & co. inc.<sep>
</APPLICANT>
<INVENTOR>
field arthur kirk<sep>scattergood edgar<sep>tytell alfred a<sep>field, arthur kirk<sep>scattergood, edgar<sep>tytell, alfred a.<sep>field, arthur kirk376 meadowbrook roadnorth wales, m.r. 1 pennsylvania 19454us<sep>scattergood, edgar1375 steven lanelansdale, pennsylvania 19446us<sep>tytell, alfred a.113 church roadlansdale, pennsylvania 19446us<sep>field, arthur kirk<sep>scattergood, edgar <sep>tytell, alfred a.  <sep>field, arthur kirk376 meadowbrook roadnorth wales, m.r. 1 pennsylvania 19454us<sep>scattergood, edgar1375 steven lanelansdale, pennsylvania 19446us<sep>tytell, alfred a.113 church roadlansdale, pennsylvania 19446us<sep>
</INVENTOR>
<ABSTRACT>
the invention provides an improved process for the  growth of lymphoblastoid cells in a medium supplemented  with human albumin.  the invention further provides for the  production of interferon by viral infection of these lymphobÂ­ lastoid cells in a medium also supplemented with human  albumin.  this invention eliminates the necessity for adding  animal proteins.  
</ABSTRACT>
</TEXT>
</DOC>
